Spinal fusion is a standard of surgical care for many patients with lumbar or cervical disorders. Degenerative disc disease, spinal stenosis, spondylolisthesis, and trauma typify causes of lumbar and cervical problems. Indications for fusion include spinal instability, intractable pain, and neurological dysfunction.
While surgeons agree that the goal of spinal fusion is solid arthrodesis, this is difficult to achieve in patients at risk for non-union. In fact, of the approximately 661,0001 spinal fusions performed in 2009, the incidence of pseudarthrosis reported in the literature varied widely, ranging from 66%2 to 95%.3 In addition, revision procedures are costly, difficult surgeries with lower success rates compared to primary fusion surgeries.4-5
This Physicians’ Guide provides important information to improve fusion outcomes in high-risk patients. Identifying patients at-risk for pseudarthrosis is the first step followed by applying Orthofix® bone growth stimulation (BGS) as adjunctive therapy for lumbar or cervical fusion, or as a non-surgical alternative for failed lumbar fusion.
Orthofix Spinal-Stim® and Cervical-Stim® BGS facilitates vascularization, mineralization of osteoid material, and promotes osteoblastic migration essential in bone healing.6 These FDA-approved devices utilize pulsed electromagnetic field (PEMF) technology. The efficacy of PEMF technology is well-supported in lumbar and cervical studies.
Todd McCall, MD received no remuneration for his testimonial video commentaries.
Jonathan P. Partington, MD received no remuneration for his testimonial video commentaries.